Friday, July 10, 2026

pharma · Chronic Hepatitis D Infection · Chronic Hepatitis Delta Infection

Blue Earth Diagnostics

Blue Earth Diagnostics clinical programs — 3 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Magdalen Centre, The Oxford Science Park, Oxford, OX4 4GA, GB HQ
2014 Founded
120 Employees
EMA registrant Type
Company details
Status
Public
HQ
Magdalen Centre, The Oxford Science Park, Oxford, OX4 4GA, GB
Founded
2014
Employees
120
Programs
11
Drugs
12
Patents
0
Intelligence · Clinical Programs

Blue Earth Diagnostics projects

3 ClinicalTrials.gov programs sponsored by Blue Earth Diagnostics.

Blue Earth Diagnostics has 3 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. BET-PSMA-001

    Blue Earth Diagnostics Ireland Ltd

    PSMA-positive non-curative metastatic castration-resistant prostate cancer

    phase 1 small molecule active

    1 trial
  2. BS-02

    Blue Earth Diagnostics Ireland Ltd

    Treatment of human papilloma virus (HPV) associated infections, precancers and cancers

    phase 1 other active

    1 trial
  3. BS-03

    Blue Earth Diagnostics Ireland Ltd

    Treatment of human papilloma virus (HPV) associated infections and cancers

    phase 1 other active

    1 trial

Frequently asked questions

How many clinical projects does Blue Earth Diagnostics have?

3 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.